Postoperative Pain
Conditions
Brief summary
In this study, the invistigators aim to compare postoperative analgesia effectiveness between combined interspace between the popliteal artery and posterior capsule of the knee block (IPACK) and Adductor canal block vs. Adductor canal block alone after Arthroscopic knee surgeries.
Detailed description
Patients who fulfilled the inclusion criteria and agreed to participate in the study will be randomly divided into two groups using their computer-generated random numbers such that even numbers will be enrolled in group A for Adductor canal block alone and odd numbers will be enrolled in group B for Adductor canal block and IPACK block.
Interventions
The patients in group A will receive adductor canal block after spinal anesthesia under a high-frequency ultrasound guidance (SonoSite™, Inc., Bothell, WA 98021, USA) in which the patients are placed in the supine position with the arms resting comfortably across the chest and the affected lower extremity is externally rotated. Adductor canal was identified beneath the sartorius muscle and 22-gauge 90-mm spinal needle is inserted from anterolateral to posteromedial direction at a point approximately at the junction between the middle and distal third of the thigh on the anteromedial femur, this location is called mid adductor canal, then 20 ml of 0.25% bupivacaine is injected in the canal
The patients in Group B will receive adductor canal block as described in group A then IPACK block, in which the patients are placed in a supine position and knee is placed in position of 90° flexion. A low-frequency ultrasound probe is positioned in the popliteal crease 1 finger breadth above the patella, and a spinal needle is inserted from the medial aspect of the knee from anteromedial to posterolateral direction in a plane between the popliteal artery and the femur. The tip of the needle is placed 1-2 cm beyond the lateral edge of the artery, and 20 ml of 0.25% bupivacaine is injected while the needle is being withdrawn after negative aspiration.
Sponsors
Study design
Eligibility
Inclusion criteria
* Physical status: ASA 1 or 2 * Age group: 21-40 years. * No sex predilection. * Patients undergoing arthroscopic knee surgery under spinal anesthesia.
Exclusion criteria
* Patient refusal * Physical status: ASA III or above. * Patients with contraindications for spinal anesthesia. * Patients with history of drug allergies to study drugs. * Evidence of local infection at site of injection. * Neuromuscular pathology (example: - Multiple Sclerosis)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Assessment of pain using the visual analogue scale (VAS) at 2 hours, 4 hours, 6 hours, and 8 hours after the completion of the surgical procedure and skin closure. | 8 hours | Visual analogue scale (VAS) (scale 0-10, where 0 = no pain and 10 = worst imaginable pain). All the patients will have the VAS score explained and taught for self-assessment of pain at the time of enrolment for the study. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Total pethidine consumption | 24 hours | Total pethidine consumption (in mg.) over 24-hour period post-operative |
| The time till first analgesic requirement | as requested by patient | The time (in hours) after finishing of ultrasound guided IPACK or Adductor canal blocks till the patient's requirement for first analgesia postoperative in ward. (All patients will receive intravenous pethidine (30mg) when VAS \> 4 at any time of assessment) |
| The number of steps | 24 hours | ambulation distance assessed by the number of steps walked by the patient 24 hours after the surgery |
Countries
Egypt